Rhamnazin
Rhamnazin (3',7-Dimethylquercetin) is an orally bioavailable small molecule that acts as a VEGFR2 kinase inhibitor. Its anti-angiogenic and anti-tumor properties are studied in leukemia research, with both in vitro cellular assays and in vivo animal models demonstrating its potential therapeutic effects.
Product Specifications
CAS Number
552-54-5
Product Name Alternative
3',7-Dimethylquercetin, Rhamnazin
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.82% (May vary between batches)
Smiles
O=C1C (O) =C (OC2=CC (OC) =CC (O) =C12) C=3C=CC (O) =C (OC) C3
Molecular Formula
C17H14O7
Molecular Weight
330.29
Storage Conditions
Keep away from direct sunlight, keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
251778-ML405 100 µL
SMAD1 (SMAD Family Member 1, BSP1, JV4-1, JV41, MADH1, MADR1) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
